Salmonella Outbreak is Linked to Onions

Real Kosher Ice Cream Recalls Soft Serve on the Go Cups Because of Possible Health Risk

FDA Says Seniors Can Get Additional Dose of COVID-19 Booster

FDA to Authorize Second Bivalent COVID-19 Shot

Two New CDC Respiratory Disease Dashboards Released

CDC Outlines Steps Being Taken to Get More Boosters to LTC Residents

Updated Booster Shot Prevents a Majority of COVID Hospitalizations in Older Adults

Supreme Court Will Not Hear Challenge to CMS Vaccination Mandate for Healthcare Workers

CDC Updates COVID-19 IPC Recommendations for Healthcare Personnel

CDC signs off on new COVID-19 boosters ahead of fall booster campaign

COVID-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon

Preparing Your Staff and Residents for COVID and More This Fall

Moving Forward with Infection Prevention and Control

U.S. Reaches $1.74 Billion Deal With Moderna for Updated Covid-19 Shots

CDC Approves New COVID-19 Vaccine Novavax

COVID Vaccines Saved 20 Million Lives in 1st Year, Scientists Say

FDA Advisers Recommend Updated Boosters Targeting Forms of Omicron

COVID-19 Vaccinations Approved for Children as Young as 6 Months Old

FDA authorizes second booster shot for people age 50 and up

Moderna asks FDA to authorize second booster for adults

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose for Older Adults

Moderna Vaccine Gets Full FDA Approval

CDC Recommends mRNA Vaccines Over Johnson & Johnson

Boosters Recommended for Ages 16-17; Preventive Use of Monoclonal Antibodies Gets EUA

Updated Testing Information Available

CDC Says 18+ ‘Should’ Get Booster

COVID Pill Treatment Closer to Emergency Use Authorization

Omicron Variant: Resources to Keep Up with the Changing Picture

Boosters for All Move Goes to CDC Committee

Vaccine Approved for Ages 5 to 11

CDC OKs Fourth Shot for Immunocompromised

FDA Committee Recommends Allowing Vaccine for Ages 5-11

CDC Expands Booster Eligibility, OKs Mix and Match

FDA Authorizes ‘Mix and Match’ Boosters

Johnson & Johnson Booster Recommended for All 18 and Older

FDA Expert Panel Recommends Moderna Booster Dose for Those 65 and Older

New Guidance: COVID-19 Booster and Flu Vaccination Considerations for Senior Living Communities

CDC Director Approves Booster Dose of Pfizer COVID-19 Vaccine for Older Adults, At-Risk Workers

FDA Authorizes Booster Dose of Pfizer COVID-19 Vaccine for Those 65+

FDA Expert Panel Recommends Pfizer Booster Dose for Those 65 and Older

FDA Gives Full Approval to Pfizer COVID-19 Vaccine

Stay Tuned: COVID-19 Booster Vaccinations Ahead for Residents, Staff

CDC Releases New Mask Guidance for Fully Vaccinated People

Now Open: Provider Relief Fund Reporting Portal

CDC Publishes Updated Guidance for Fully Vaccinated Residents, Workers in Assisted Living

Expiration Date Extended on BinaxNOW Tests

Argentum Releases Visitation Guidance for Vaccinated Senior Living Communities

CDC Releases Guidance for Safe Visitation in Long-Term Care

CDC Releases Interim Public Health Recommendations for Fully Vaccinated People

Press Release: Congress Fails Seniors and Caregivers in COVID Relief Package

FDA Issues EUA for Johnson & Johnson COVID-19 Vaccine

Press Release: Seniors and Caregivers Continue to be Overlooked in COVID-19 Relief Negotiations

New Guidance: Resident Engagement and Socialization During COVID-19

HHS Adds New Questions and Answers to Provider Relief Fund FAQs

HHS Updates Provider Relief Fund Reporting Guidelines

CDC Launches New COVID-19 Data Tracker for Pharmacy Partnership for Long-Term Care Program

HHS Announces Provider Relief Fund Reporting Update

A Look at Current Vaccine Trends in Distribution and Administration Across Long-Term Care

CDC Rolls Out Long-Term Care Vaccination Toolkit

New COVID-19 Relief Package Falls Short in Supporting Long-Term Care

FDA Issues EUA for Moderna COVID-19 Vaccine

FDA Advisory Panel Recommends Moderna COVID-19 Vaccine for EUA

FDA Issues EUA for BinaxNOW COVID-19 Home Test

A Pivotal Announcement from HHS on Phase 3 Funding

FDA Issues EUA for the Pfizer COVID-19 Vaccine

FDA Advisory Committee Endorses Pfizer’s COVID-19 Vaccine

Take Action Today: Call on Congress to Pass Bipartisan COVID-19 Legislation

Framework of the Bipartisan Emergency COVID Relief Act of 2020 Includes Additional $35 Billion for the Provider Relief Fund

Argentum Members: Join our Vaccine Readiness Briefing on Monday, Dec. 14

Recommended Action Items: COVID-19 Vaccine Distribution and Prioritization

Long-Term Care and Senior Living Leaders Emphasize Need for Residents and Staff to Receive Prioritization for COVID-19 Vaccine Distribution

Tips to Prepare for COVID-19 Vaccine Distribution

Join Us Nov. 19 for a Virtual Senior Living Congressional Briefing

Deadline Today: Apply for Phase 3 Funding from CARES Act Provider Relief Fund

Deadline Today: Opt-In to HHS Vaccine Program

Recording Now Available: Call with HHS’ Nick Uehlecke on CARES Act Provider Relief Funding

A Status Update on COVID-19 Vaccine Trials

CMS Announces Plan to Cover COVID-19 Vaccine Costs

HHS Pharmacy Partnership Program Sign-Up Extended to November 6

Reminder and New Information on HHS’ Pharmacy Partnership

HHS Updates Provider Relief Fund Reporting Requirements

Register for Upcoming COVID-19 Member-Only Webinars

HHS Announces Partnership with Pharmacies for Vaccine Management for Long-Term Care Communities

Additional Details on Phase 3 Funding from the HHS Provider Relief Fund

Key Takeaways from CDC Call on Vaccine Distribution

Update on CLIA Waivers & Rapid Point-of-Care Testing

National Academies Releases Final COVID-19 Vaccine Report

HHS Announces Phase 3 General Distribution

CDC Releases Vaccination Program Interim Playbook

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:


Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.